{"id":"https://openalex.org/W2328635004","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.9109","title":"A phase III randomized controlled study comparing iron sucrose intravenously (IV) to no iron treatment of anemia in cancer patients undergoing chemotherapy and erythropoietin stimulating agent (ESA) therapy","display_name":"A phase III randomized controlled study comparing iron sucrose intravenously (IV) to no iron treatment of anemia in cancer patients undergoing chemotherapy and erythropoietin stimulating agent (ESA) therapy","publication_year":2007,"publication_date":"2007-06-20","ids":{"openalex":"https://openalex.org/W2328635004","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.9109","mag":"2328635004"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.25.18_suppl.9109","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.9109","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.9109","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109380757","display_name":"Robert E. Bellet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108891","display_name":"Newland Medical Associates","ror":"https://ror.org/020szg916","country_code":"US","type":"other","lineage":["https://openalex.org/I4210108891"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. E. Bellet","raw_affiliation_strings":["Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA","institution_ids":["https://openalex.org/I4210108891"]}]},{"author_position":"middle","author":{"id":null,"display_name":"H. Ghazal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108891","display_name":"Newland Medical Associates","ror":"https://ror.org/020szg916","country_code":"US","type":"other","lineage":["https://openalex.org/I4210108891"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Ghazal","raw_affiliation_strings":["Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA","institution_ids":["https://openalex.org/I4210108891"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005466085","display_name":"Marshall S. Flam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108891","display_name":"Newland Medical Associates","ror":"https://ror.org/020szg916","country_code":"US","type":"other","lineage":["https://openalex.org/I4210108891"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Flam","raw_affiliation_strings":["Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA","institution_ids":["https://openalex.org/I4210108891"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074575716","display_name":"Anibal Drelichman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108891","display_name":"Newland Medical Associates","ror":"https://ror.org/020szg916","country_code":"US","type":"other","lineage":["https://openalex.org/I4210108891"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Drelichman","raw_affiliation_strings":["Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA","institution_ids":["https://openalex.org/I4210108891"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087372519","display_name":"N. Gabrail","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108891","display_name":"Newland Medical Associates","ror":"https://ror.org/020szg916","country_code":"US","type":"other","lineage":["https://openalex.org/I4210108891"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Gabrail","raw_affiliation_strings":["Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA","institution_ids":["https://openalex.org/I4210108891"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007526473","display_name":"Donald Woytowitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108891","display_name":"Newland Medical Associates","ror":"https://ror.org/020szg916","country_code":"US","type":"other","lineage":["https://openalex.org/I4210108891"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Woytowitz","raw_affiliation_strings":["Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA","institution_ids":["https://openalex.org/I4210108891"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Loesch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108891","display_name":"Newland Medical Associates","ror":"https://ror.org/020szg916","country_code":"US","type":"other","lineage":["https://openalex.org/I4210108891"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Loesch","raw_affiliation_strings":["Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA","institution_ids":["https://openalex.org/I4210108891"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072776178","display_name":"Demi Niforos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108891","display_name":"Newland Medical Associates","ror":"https://ror.org/020szg916","country_code":"US","type":"other","lineage":["https://openalex.org/I4210108891"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Niforos","raw_affiliation_strings":["Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA","institution_ids":["https://openalex.org/I4210108891"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067596161","display_name":"Antoinette Mangione","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108891","display_name":"Newland Medical Associates","ror":"https://ror.org/020szg916","country_code":"US","type":"other","lineage":["https://openalex.org/I4210108891"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Mangione","raw_affiliation_strings":["Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA","institution_ids":["https://openalex.org/I4210108891"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005448318","display_name":"Lowell Brian Anthony","orcid":"https://orcid.org/0000-0001-7348-7874","observed_orcids":["https://orcid.org/0000-0001-7348-7874"]},"institutions":[{"id":"https://openalex.org/I4210108891","display_name":"Newland Medical Associates","ror":"https://ror.org/020szg916","country_code":"US","type":"other","lineage":["https://openalex.org/I4210108891"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Anthony","raw_affiliation_strings":["Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Luitpold Pharmaceuticals, Elkins Park, PA; Kentucky Cancer Clinic, Hazard, KY; Hematology/Oncology Group of Fresno, Fresno, CA; Newland Medical Associates, Southfield, MI; Nashat Cancer Cneter, Canton, OH; Florida Cancer Specialists, Ft. Myers, FL; Oncology/Hematology Associates, Indianapolis, IN; AAI Pharma, Natick, MA; Luitpold, Norristown, PA; LSUHSC New Orleans, New Orleans, LA","institution_ids":["https://openalex.org/I4210108891"]}]},{"author_position":"last","author":{"id":null,"display_name":"Iron Sucrose Study Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Iron Sucrose Study Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"18_suppl","first_page":"9109","last_page":"9109"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/iron-sucrose","display_name":"iron sucrose","score":0.9919999837875366},{"id":"https://openalex.org/keywords/chemotherapy-induced-anemia","display_name":"chemotherapy-induced anemia","score":0.8799999952316284},{"id":"https://openalex.org/keywords/cancer-patients","display_name":"cancer patients","score":0.7110000252723694},{"id":"https://openalex.org/keywords/erythropoiesis-stimulating-agents","display_name":"erythropoiesis-stimulating agents","score":0.9279999732971191},{"id":"https://openalex.org/keywords/darbepoetin-alfa","display_name":"darbepoetin alfa","score":0.9470000267028809},{"id":"https://openalex.org/keywords/epoetin","display_name":"epoetin","score":0.9760000109672546},{"id":"https://openalex.org/keywords/intravenous-iron","display_name":"intravenous iron","score":0.6470000147819519},{"id":"https://openalex.org/keywords/hemoglobin-response","display_name":"hemoglobin response","score":0.8209999799728394},{"id":"https://openalex.org/keywords/iron-stores","display_name":"iron stores","score":0.9430000185966492},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.8180000185966492},{"id":"https://openalex.org/keywords/hypotension","display_name":"hypotension","score":0.625},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.44999998807907104}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9264533519744873},{"id":"https://openalex.org/C2776974161","wikidata":"https://www.wikidata.org/wiki/Q6073050","display_name":"Iron sucrose","level":5,"score":0.9120736718177795},{"id":"https://openalex.org/C2781404941","wikidata":"https://www.wikidata.org/wiki/Q2178381","display_name":"Darbepoetin alfa","level":3,"score":0.7587356567382812},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.7141035795211792},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6484221816062927},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5562804937362671},{"id":"https://openalex.org/C2778534260","wikidata":"https://www.wikidata.org/wiki/Q218706","display_name":"Erythropoietin","level":2,"score":0.5488978028297424},{"id":"https://openalex.org/C2776164570","wikidata":"https://www.wikidata.org/wiki/Q5383794","display_name":"Epoetin alfa","level":3,"score":0.5460177063941956},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5402355790138245},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5390111804008484},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5261608958244324},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4496493935585022},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.40632033348083496},{"id":"https://openalex.org/C2777417653","wikidata":"https://www.wikidata.org/wiki/Q1313081","display_name":"Iron deficiency","level":3,"score":0.3144967555999756},{"id":"https://openalex.org/C3020614022","wikidata":"https://www.wikidata.org/wiki/Q769796","display_name":"Intravenous iron","level":4,"score":0.13989365100860596}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2007.25.18_suppl.9109","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.9109","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.9109","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4281926584","https://openalex.org/W2529282066","https://openalex.org/W2604234563","https://openalex.org/W2356381903","https://openalex.org/W2085502168","https://openalex.org/W2567543754","https://openalex.org/W2999901283","https://openalex.org/W1819963936","https://openalex.org/W2964996757","https://openalex.org/W2557802366"],"abstract_inverted_index":{"9109":[0],"Background:":[1],"The":[2],"effect":[3],"of":[4,28,44,89,99,132,135,142,150,157,160,172,202,265],"using":[5],"IV":[6,29,276,306],"iron":[7,30,143,165,231,235,240,247,255,277,283,307],"sucrose":[8,31,144,185,236,248,256,278,308],"in":[9,32,73,115,146,193,214,228,233,269,290,297,312,317],"managing":[10],"cancer":[11,36,302,319],"chemotherapy-related":[12,37],"anemia":[13,38,64],"has":[14],"not":[15,243],"been":[16],"previously":[17],"reported.":[18],"To":[19],"investigate":[20],"this":[21],"issue,":[22],"we":[23],"conducted":[24,72],"a":[25,224,270],"randomized":[26,123],"study":[27],"patients":[33,300,320],"(pts)":[34],"with":[35,61,84,120,301,314],"who":[39,204],"completed":[40],"8":[41],"prior":[42,216],"wks":[43,131,156],"ESA":[45,86,109,118,136,161,187,190,217,298],"therapy.":[46,249],"Methods:":[47],"This":[48],"prospective,":[49],"multicenter,":[50],"randomized,":[51],"open":[52],"label,":[53],"Phase":[54],"III":[55],"clinical":[56],"trial":[57],"enrolled":[58],"375":[59],"pts":[60,81,203],"chemotherapy":[62],"induced":[63],"(Hgb":[65],"levels":[66,198,281],"=":[67,208],"10.0":[68],"g/dL)":[69],"and":[70,167,174,181,199,210,219,230,282,286],"was":[71,222],"2":[74],"stages.":[75],"During":[76],"Stage":[77],"I":[78],"(8-wk":[79],"duration),":[80],"received":[82],"treatment":[83],"fixed":[85,133,158],"doses":[87,134,149,159,291],"(100-mcg":[88],"darbepoetin":[90,100],"or":[91,96,117,154],"40,000":[92],"units":[93],"epoetin":[94],"wkly":[95],"200":[97],"mcg":[98],"every":[101],"other":[102],"wk).":[103],"Pts":[104],"were":[105,177,260],"classified":[106],"as":[107],"either":[108,129],"responders":[110,218],"(=":[111],"1":[112],"g/dL":[113],"increase":[114],"Hgb)":[116],"non-responders":[119],"each":[121],"group":[122],"(Stage":[124],"2)":[125],"separately":[126],"to":[127,139,152,189,246,293],"receive":[128],"12":[130,155],"plus":[137,186],"up":[138,151,292],"1,500":[140],"mg":[141,295],"(given":[145],"3":[147],"divided":[148],"500mg)":[153],"alone.":[162],"Laboratories":[163],"(including":[164],"indices":[166],"acute":[168],"phase":[169],"reactants),":[170],"quality":[171],"life":[173],"adverse":[175,258],"events":[176,259],"assessed":[178],"at":[179],"baseline":[180],"throughout.":[182],"Results:":[183],"Iron":[184],"compared":[188],"alone":[191],"resulted":[192],"greater":[194,200],"mean":[195],"maximum":[196],"Hgb":[197,206,280],"number":[201],"achieved":[205],"increases":[207],"2.0":[209],"\u2265":[211],"3.0":[212],"g/dl":[213],"both":[215],"non-responders.":[220],"There":[221],"also":[223],"statistically":[225],"significant":[226],"improvement":[227],"fatigue":[229],"stores":[232,284],"the":[234],"treated":[237,299],"pts.":[238],"Baseline":[239],"status":[241],"did":[242],"predict":[244],"responsiveness":[245],"Three":[250],"serious":[251],"but":[252],"non-life":[253],"threatening":[254],"related":[257,304],"observed":[261],"including":[262],"one":[263],"case":[264],"significant,":[266],"transient":[267],"hypotension":[268],"female":[271],"weighing":[272],"50":[273],"kg.":[274],"Conclusions:":[275],"increased":[279],"significantly":[285],"is":[287],"well":[288],"tolerated":[289],"500":[294],"increments":[296],"chemotherapy-":[303],"anemia.":[305],"should":[309],"be":[310],"considered":[311],"combination":[313],"erythropoietic":[315],"therapy":[316],"anemic":[318],"receiving":[321],"chemotherapy.":[322],"[Table:":[323],"see":[324],"text]":[325]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}